KIF4A-based multi-gene signatures, such as KIF4A + RAD51AP1 + CDKN3 in oesophageal cancer, are poised to enter clinical practice as routine tools for molecular diagnostics and prognostic predictions, enabling more precise patient stratification. This evidence concerns the gene RAD51AP1 and carcinoma of esophagus.